Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	2.02B
Revenue (ttm)	724.35M
Net Income (ttm)	134.23M
Shares Out	18.42M
EPS (ttm)	7.26
PE Ratio	15.08
Forward PE	n/a
Dividend	7.00 (6.33%)
Ex-Dividend Date	Jun 13, 2025

Volume	13,733
Average Volume	15,778
Open	110.00
Previous Close	109.50
Day's Range	107.50 - 110.00
52-Week Range	85.70 - 117.50
Beta	0.05
RSI	47.87
Earnings Date	Nov 12, 2025

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. It offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tables, film coated tablets, chewables, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2024, Winston Medical Supply's revenue was 695.08 million, a decrease of -1.97% compared to the previous year's 709.07 million. Earnings were 131.59 million, a decrease of -17.11%.